Artiva Biotherapeutics (ARTV) Accumulated Depreciation & Amortization (2023 - 2025)
Historic Accumulated Depreciation & Amortization for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $7.8 million.
- Artiva Biotherapeutics' Accumulated Depreciation & Amortization rose 4662.91% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 4662.91%. This contributed to the annual value of $5.9 million for FY2024, which is 6769.54% up from last year.
- Latest data reveals that Artiva Biotherapeutics reported Accumulated Depreciation & Amortization of $7.8 million as of Q3 2025, which was up 4662.91% from $7.2 million recorded in Q2 2025.
- Artiva Biotherapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $7.8 million during Q3 2025, with a 5-year trough of $1.1 million in Q2 2023.
- Over the past 3 years, Artiva Biotherapeutics' median Accumulated Depreciation & Amortization value was $5.6 million (recorded in 2024), while the average stood at $4.8 million.
- As far as peak fluctuations go, Artiva Biotherapeutics' Accumulated Depreciation & Amortization skyrocketed by 663.08% in 2024, and later soared by 50184.87% in 2025.
- Artiva Biotherapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $3.5 million in 2023, then surged by 67.7% to $5.9 million in 2024, then soared by 31.83% to $7.8 million in 2025.
- Its Accumulated Depreciation & Amortization was $7.8 million in Q3 2025, compared to $7.2 million in Q2 2025 and $6.5 million in Q1 2025.